title: Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction.
abstract: Myocardial infarction (MI) is a common complex disease with a genetic component. While several single nucleotide polymorphisms (SNPs) have been reported to be associated with risk of MI, they do not fully explain the observed genetic component of MI. We have been investigating the association between MI and SNPs that are located in genes and have the potential to affect gene function or expression. We have previously published studies that tested about 12,000 SNPs for association with risk of MI, early-onset MI, or coronary stenosis. In the current study we tested 17,576 SNPs that could affect gene function or expression. In order to use genotyping resources efficiently, we staged the testing of these SNPs in three case-control studies of MI. In the first study (762 cases, 857 controls) we tested 17,576 SNPs and found 1,949 SNPs that were associated with MI (P<0.05). We tested these 1,949 SNPs in a second study (579 cases and 1159 controls) and found that 24 SNPs were associated with MI (1-sided P<0.05) and had the same risk alleles in the first and second study. Finally, we tested these 24 SNPs in a third study (475 cases and 619 controls) and found that 5 SNPs in 4 genes (ENO1, FXN (2 SNPs), HLA-DPB2, and LPA) were associated with MI in the third study (1-sided P<0.05), and had the same risk alleles in all three studies. The false discovery rate for this group of 5 SNPs was 0.23. Thus, we have identified 5 SNPs that merit further examination for their potential association with MI. One of these SNPs (in LPA), has been previously shown to be associated with risk of cardiovascular disease in other studies.
authors.affiliation: Celera, Alameda, California, United States of America. dov.shiffman@celera.com
authors.forename: Dov
authors.initials: D
authors.lastname: Shiffman
authors.forename: John P
authors.initials: JP
authors.lastname: Kane
authors.forename: Judy Z
authors.initials: JZ
authors.lastname: Louie
authors.forename: Andre R
authors.initials: AR
authors.lastname: Arellano
authors.forename: David A
authors.initials: DA
authors.lastname: Ross
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Catanese
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Malloy
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Ellis
authors.forename: James J
authors.initials: JJ
authors.lastname: Devlin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D001054:Apolipoproteins A / Q000235:genetics; D016022:Case-Control Studies; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D033862:Iron-Binding Proteins / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000235:genetics*; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D000096923:Frataxin
chemical_list: D001054:Apolipoproteins A; D033862:Iron-Binding Proteins; D000096923:Frataxin